β Blocker Use and Mortality in Hospital Survivors of Acute Myocardial Infarction Without Heart Failure
NCT ID: NCT02786654
Last Updated: 2019-06-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
179810 participants
OBSERVATIONAL
2007-01-31
2013-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The PACE-MI Registry Study - Outcomes of Beta-blocker Therapy After Myocardial Infarction (OBTAIN)
NCT00430612
Abciximab i.v. Versus i.c. in ST-elevation Myocardial Infarction
NCT00712101
Management of Acute Myocardial Infarction in the Presence of Left Bundle Branch Block
NCT01494870
Effects of Long-term Remote Ischemic Preconditioning on Clinical Outcome in Patients With Acute Myocardial Infarction
NCT07181356
Impact of Cardio-Selective Beta-Blockers on Infarct Size After Acute Myocardial Infarction
NCT07293832
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* aged 18 to 100 years
Exclusion Criteria
* died in-hospital
* patients with missing mortality data
* aged \> 100
* patients with previous acute myocardial infarction or angina
* patients who have received coronary interventions before
* patients with heart failure
* patients with β blocker prior use
* patients contraindicated for β blocker use
* patients with use of a loop diuretic
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Leeds
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tatendashe Bernadette Dondo
Research assistant
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Chris P Gale, FRCP
Role: PRINCIPAL_INVESTIGATOR
University of Leeds
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Leeds
Leeds, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Dondo TB, Hall M, West RM, Jernberg T, Lindahl B, Bueno H, Danchin N, Deanfield JE, Hemingway H, Fox KAA, Timmis AD, Gale CP. beta-Blockers and Mortality After Acute Myocardial Infarction in Patients Without Heart Failure or Ventricular Dysfunction. J Am Coll Cardiol. 2017 Jun 6;69(22):2710-2720. doi: 10.1016/j.jacc.2017.03.578.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PG/13/81/30474BB
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.